Call us Become a distributor
Tablet Antibiotics & Anti-infectives

Resafe-CV

“The tough combination for tough situations”

A cephalosporin and clavulanic acid tablet for resistant and nosocomial bacterial infections.

Resafe-CV product information card showing composition and indications Tap to enlarge

Original Resafe-CV product literature

Composition
Cefpodoxime Proxetil 200 mg + Clavulanic Acid 125 mg
Dosage form
Tablet

Indications

  • Nosocomial infections
  • Uncomplicated UTI
  • Otitis media
  • Surgical prophylaxis
  • Resistant typhoid fever
  • Resistant respiratory tract infections

Key points

  • Broad spectrum third generation cephalosporin
  • Suits switch-over therapy from injectable to oral
  • Excellent gram-positive and gram-negative coverage
  • Clavulanic acid inhibits bacterial beta-lactamases
Prescription note. This page reproduces the manufacturer's product literature for reference by healthcare professionals and trade partners. It is not a substitute for medical advice. Use only as directed by a registered medical practitioner.

Related

More in Antibiotics & Anti-infectives